ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma

NCT00407407 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped MTD not determined

Conditions

Fallopian Tube Neoplasms
Peritoneal Neoplasms
Ovarian Neoplasms

Interventions

DRUG: ABI-007
DRUG: Carboplatin

Sponsor

Celgene